North America High-Throughput Genomic Screening For Preventive Healthcare Market Size & Outlook
The high-throughput genomic screening for preventive healthcare market in North America is expected to reach a projected revenue of US$ 1,069.9 million by 2033. A compound annual growth rate of 12.1% is expected of North America high-throughput genomic screening for preventive healthcare market from 2026 to 2033.
- Clinical Diagnostics
- Genetic Testing
- High-Throughput Genomic Screening for Preventive Healthcare Market Outlook
- Genetic Testing